Authors: Carter, Bing Z, Mak, Po Yee, Tao, Wenjing, Ostermann, Lauren B, Boettcher, Steffen, Nishida, Yuki, Ayoub, Edward, Ruvolo, Vivian, Jabbour, Elias J., Hughes, Paul, Morrow, PK, Andreeff, Michael

Source: Blood; November 2021, Vol. 138 Issue: 1, Number 1 Supplement 1 p2239-2239, 1p

Authors: Carter, Bing Z, Mak, Po Yee, Ruvolo, Vivian, Tao, Wenjing, Hughes, Paul, Chen, Xiaoyue, Morrow, PK, Andreeff, Michael

Source: Blood; November 2020, Vol. 136 Issue: 1, Number 1 Supplement 1 p30-31, 2p

Authors: Carter, Bing Z, Mak, Po Yee, Tao, Wenjing, Ruvolo, Vivian, Zhang, Xuan, Nishida, Yuki, Kornblau, Steven M., Hughes, Paul, Chen, Xiaoyue, Morrow, PK, Andreeff, Michael

Source: Blood; November 2020, Vol. 136 Issue: 1, Number 1 Supplement 1 p7-7, 1p

Authors: Carter, Bing Z, Tao, Wenjing, Mak, Po Yee, Zhang, Qi, Wang, Xiangmeng, Kuruvilla, Vinitha Mary, Stewart, Carli, Ruvolo, Vivian, Battula, Venkata Lokesh, Konopleva, Marina Y, Caenepeel, Sean, Canon, Jude, Hughes, Paul, Morrow, PK, Andreeff, Michael

Source: Blood; November 2019, Vol. 134 Issue: 1, Number 1 Supplement 1 p1267-1267, 1p

Authors: Dale, David C., Bolyard, Audrey Anna, Zeidler, Cornelia, Marrero, Tracy M., Boxer, Laurence A., Newburger, Peter E., Alter, Blanche P., Morrow, PK, Bonilla, Mary Ann, Dror, Yigal, Firkin, Frank, Kinsey, Sally, Levine, John E., Link, Daniel C., Reeves, Lee, Rosenberg, Philip S., Shimamura, Akiko, Welte, Karl

Source: Blood; December 2014, Vol. 124 Issue: 21 p2730-2730, 1p

Authors: Langeberg, Wendy J, Siozon, Conchitina C, Morrow, PK, Page, John H, Chia, Victoria M

Source: Blood; November 2013, Vol. 122 Issue: 21 p5598-5598, 1p

Authors: Stewart MD; Friends of Cancer Research. Electronic address: mstewart@focr.org., McCall B; Genentech, A Member of the Roche Group., Pasquini M; Medical College of Wisconsin, Center for International Blood and Marrow Transplant Research., Yang AS; Xencor., Britten CD; Amgen., Chuk M; Food and Drug Administration., De Claro RA; Food and Drug Administration., George B; Food and Drug Administration., Gormley N; Food and Drug Administration., Horowitz MM; Medical College of Wisconsin, Center for International Blood and Marrow Transplant Research., Kowack E; Xencor., McCoy C; Bristol Myers Squibb., Morrow PK; Amgen., Okoye E; Regeneron Pharmaceuticals., Ricafort R; Bristol Myers Squibb., Rossi J; CERo Therapeutics., Sharon E; National Cancer Institute., Theoret M; Food and Drug Administration., Vegni F; Bristol Myers Squibb., Yu T; Amgen., Allen J; Friends of Cancer Research.

Source: Cytotherapy [Cytotherapy] 2022 Jul; Vol. 24 (7), pp. 742-749. Date of Electronic Publication: 2022 Feb 23.

Publication Type: Journal Article

Journal Info: Publisher: Elsevier Country of Publication: England NLM ID: 100895309 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1477-2566 (Electronic) Linking ISSN: 14653249 NLM ISO Abbreviation: Cytotherapy Subsets: MEDLINE

MeSH Terms: Cytokine Release Syndrome*/etiology , Immunotherapy*/adverse effects , Neoplasms*/therapy, Antibodies, Bispecific ; Clinical Trials as Topic ; Humans ; Immunotherapy, Adoptive/adverse effects

Authors: Carter BZ; Section of Molecular Hematology and Therapy, Department of Leukemia, The University of Texas MD Anderson Cancer Center, Houston, Texas., Mak PY; Section of Molecular Hematology and Therapy, Department of Leukemia, The University of Texas MD Anderson Cancer Center, Houston, Texas., Tao W; Section of Molecular Hematology and Therapy, Department of Leukemia, The University of Texas MD Anderson Cancer Center, Houston, Texas., Zhang Q; Section of Leukemia Biological Research, Department of Leukemia, The University of Texas MD Anderson Cancer Center, Houston, Texas., Ruvolo V; Section of Molecular Hematology and Therapy, Department of Leukemia, The University of Texas MD Anderson Cancer Center, Houston, Texas., Kuruvilla VM; Section of Leukemia Biological Research, Department of Leukemia, The University of Texas MD Anderson Cancer Center, Houston, Texas., Wang X; Section of Molecular Hematology and Therapy, Department of Leukemia, The University of Texas MD Anderson Cancer Center, Houston, Texas., Mak DH; Section of Molecular Hematology and Therapy, Department of Leukemia, The University of Texas MD Anderson Cancer Center, Houston, Texas., Battula VL; Section of Molecular Hematology and Therapy, Department of Leukemia, The University of Texas MD Anderson Cancer Center, Houston, Texas., Konopleva M; Section of Leukemia Biological Research, Department of Leukemia, The University of Texas MD Anderson Cancer Center, Houston, Texas., Jabbour EJ; Department of Leukemia, The University of Texas MD Anderson Cancer Center, Houston, Texas., Hughes PE; Oncology Research, Amgen Inc., Thousand Oaks, California., Chen X; Oncology Research, Amgen Inc., Thousand Oaks, California., Morrow PK; Amgen Inc., Thousand Oaks, California., Andreeff M; Section of Molecular Hematology and Therapy, Department of Leukemia, The University of Texas MD Anderson Cancer Center, Houston, Texas.

Source: Molecular cancer therapeutics [Mol Cancer Ther] 2022 Jun 01; Vol. 21 (6), pp. 879-889.

Publication Type: Journal Article; Research Support, Non-U.S. Gov't; Research Support, N.I.H., Extramural

Journal Info: Publisher: American Association for Cancer Research, Inc Country of Publication: United States NLM ID: 101132535 Publication Model: Print Cited Medium: Internet ISSN: 1538-8514 (Electronic) Linking ISSN: 15357163 NLM ISO Abbreviation: Mol Cancer Ther Subsets: MEDLINE

MeSH Terms: Apoptosis Regulatory Proteins* , Biomimetic Materials*/pharmacology , Leukemia, Myeloid, Acute*/drug therapy , Leukemia, Myeloid, Acute*/metabolism, Animals ; Apoptosis ; Bridged Bicyclo Compounds, Heterocyclic/pharmacology ; Cell Line, Tumor ; Humans ; Mice ; Myeloid Cell Leukemia Sequence 1 Protein/genetics ; Proto-Oncogene Proteins c-bcl-2 ; Stem Cells/metabolism ; bcl-2-Associated X Protein/metabolism ; bcl-2-Associated X Protein/pharmacology

Authors: Li BT; Memorial Sloan Kettering Cancer Center, Weill Cornell Medicine, New York, NY, USA. lib1@mskcc.org., Daly B; Memorial Sloan Kettering Cancer Center, Weill Cornell Medicine, New York, NY, USA., Gospodarowicz M; Princess Margaret Cancer Center, , University of Toronto, Toronto, Ontario, Canada., Bertagnolli MM; Dana-Farber Brigham Cancer Center, Harvard Medical School, Boston, MA, USA., Brawley OW; Johns Hopkins Bloomberg School of Public Health, Baltimore, MD, USA., Chabner BA; Massachusetts General Hospital Cancer Center, Boston, MA, USA.; Society for Translational Oncology, Durham, NC, USA., Fashoyin-Aje L; Oncology Center of Excellence, Food and Drug Administration, Silver Spring, MD, USA., de Claro RA; Oncology Center of Excellence, Food and Drug Administration, Silver Spring, MD, USA., Franklin E; Cancer Support Community, Washington, DC, USA., Mills J; Foundation Medicine, Inc., Cambridge, MA, USA., Legos J; Novartis, Basel, Switzerland., Kaucic K; PPD, Inc., Wilmington, NC, USA., Li M; Resolution Bioscience, Agilent Technologies, Kirkland, WA, USA., The L; McKinsey Cancer Center, McKinsey & Company., Hou T; McKinsey Cancer Center, McKinsey & Company., Wu TH; McKinsey Cancer Center, McKinsey & Company., Albrecht B; McKinsey Cancer Center, McKinsey & Company., Shao Y; McKinsey Cancer Center, McKinsey & Company., Finnegan J; Bloomberg New Economy, Bloomberg L.P., New York, NY, USA., Qian J; Asia Society Policy Institute, Asia Society, New York, NY, USA., Shahidi J; Daiichi Sankyo, Tokyo, Japan., Gasal E; Innovent Biologics, Suzhou, China., Tendler C; Janssen, Johnson and Johnson, New Brunswick, NJ, USA., Kim G; BeiGene USA, BeiGene, Beijing, China., Yan J; Zai Lab, Shanghai, China., Morrow PK; Amgen, Inc, Thousand Oaks, CA, USA., Fuchs CS; Genentech, South San Francisco, CA, USA.; Yale Cancer Center, Yale School of Medicine, New Haven, CT, USA., Zhang L; Jiangsu Hengrui Pharmaceuticals, Shanghai, China., LaCaze R; Bayer AG, Leverkusen, Germany., Oelrich S; Bayer AG, Leverkusen, Germany., Murphy MJ; Society for Translational Oncology, Durham, NC, USA.; Shanghai TuoXin Health Promotion Center, Shanghai, China.; CEO Roundtable on Cancer, Morrisville, NC, USA., Pazdur R; Oncology Center of Excellence, Food and Drug Administration, Silver Spring, MD, USA., Rudd K; Asia Society Policy Institute, Asia Society, New York, NY, USA., Wu YL; Guangdong Lung Cancer Institute, Guangdong Provincial People's Hospital, Guangdong Academy of Medical Sciences, Chinese Thoracic Oncology Group, Guangzhou, China.

Source: Nature medicine [Nat Med] 2022 Apr; Vol. 28 (4), pp. 620-626.

Publication Type: Journal Article

Journal Info: Publisher: Nature Publishing Company Country of Publication: United States NLM ID: 9502015 Publication Model: Print Cited Medium: Internet ISSN: 1546-170X (Electronic) Linking ISSN: 10788956 NLM ISO Abbreviation: Nat Med Subsets: MEDLINE

MeSH Terms: Neoplasms*/therapy, Clinical Trials as Topic ; Humans ; Patient-Centered Care

Authors: O'Donnell PH; The University of Chicago, 5841 S. Maryland Avenue, MC 2115, Chicago, IL, 60637, USA. podonnel@medicine.bsd.uchicago.edu., Trubetskoy V; The University of Chicago, 5841 S. Maryland Avenue, MC 2115, Chicago, IL, 60637, USA.; Universitatsmedizin Berlin Campus Charite Mitte, Berlin, Germany., Nurhussein-Patterson A; The University of Chicago, 5841 S. Maryland Avenue, MC 2115, Chicago, IL, 60637, USA., Hall JP; The University of Chicago, 5841 S. Maryland Avenue, MC 2115, Chicago, IL, 60637, USA., Nath A; The University of Chicago, 5841 S. Maryland Avenue, MC 2115, Chicago, IL, 60637, USA., Huo D; The University of Chicago, 5841 S. Maryland Avenue, MC 2115, Chicago, IL, 60637, USA., Fleming GF; The University of Chicago, 5841 S. Maryland Avenue, MC 2115, Chicago, IL, 60637, USA., Ingle JN; Mayo Clinic, Rochester, USA., Abramson VG; Vanderbilt University, Nashville, USA., Morrow PK; MD Anderson Cancer Center, Houston, USA.; Amgen Inc, Thousand Oaks, USA., Storniolo AM; Indiana University, Bloomington, USA., Forero A; University of Alabama-Birmingham, Birmingham, USA., Van Poznak C; University of Michigan, Ann Arbor, USA., Liu MC; Mayo Clinic, Rochester, USA.; Georgetown University, Washington, USA., Chang JC; Baylor College of Medicine, Houston, USA., Merkel DE; NorthShore University Health System, Evanston, USA., Peppercorn JM; Duke University, Durham, USA.; Massachusetts General Hospital, Boston, USA., Rugo HS; University of California, San Francisco, USA., Dees EC; University of North Carolina, Chapel Hill, USA., Hahn OM; The University of Chicago, 5841 S. Maryland Avenue, MC 2115, Chicago, IL, 60637, USA., Hoffman PC; The University of Chicago, 5841 S. Maryland Avenue, MC 2115, Chicago, IL, 60637, USA., Rosner GL; Johns Hopkins University, Baltimore, USA., Huang RS; The University of Chicago, 5841 S. Maryland Avenue, MC 2115, Chicago, IL, 60637, USA.; University of Minnesota, Minneapolis, USA., Ratain MJ; The University of Chicago, 5841 S. Maryland Avenue, MC 2115, Chicago, IL, 60637, USA., Cox N; The University of Chicago, 5841 S. Maryland Avenue, MC 2115, Chicago, IL, 60637, USA.; Vanderbilt University, Nashville, USA., Olopade OI; The University of Chicago, 5841 S. Maryland Avenue, MC 2115, Chicago, IL, 60637, USA., Wolff AC; Johns Hopkins University, Baltimore, USA., Dolan ME; The University of Chicago, 5841 S. Maryland Avenue, MC 2115, Chicago, IL, 60637, USA., Nanda R; The University of Chicago, 5841 S. Maryland Avenue, MC 2115, Chicago, IL, 60637, USA.

Corporate Authors: Translational Breast Cancer Research Consortium (TBCRC)

Source: Breast cancer research and treatment [Breast Cancer Res Treat] 2020 Jun; Vol. 181 (3), pp. 623-633. Date of Electronic Publication: 2020 May 06.

Publication Type: Journal Article

Journal Info: Publisher: Kluwer Academic Country of Publication: Netherlands NLM ID: 8111104 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1573-7217 (Electronic) Linking ISSN: 01676806 NLM ISO Abbreviation: Breast Cancer Res Treat Subsets: MEDLINE

Authors: Crawford J; Duke University Medical Center, Trent Drive, Duke South, 25177 Morris Building, Durham, NC, 27710, USA. jeffrey.a.crawford@duke.edu., Denduluri N; Virginia Cancer Specialists, US Oncology Network, Arlington, VA, USA., Patt D; McKesson Specialty Health, The Woodlands, TX, USA., Jiao X; McKesson Specialty Health, The Woodlands, TX, USA., Morrow PK; Amgen Inc., Thousand Oaks, CA, USA., Garcia J; Amgen Inc., Thousand Oaks, CA, USA., Barron R; Amgen Inc., Thousand Oaks, CA, USA., Lyman GH; Fred Hutchinson Cancer Research Center and the University of Washington, Seattle, WA, USA.

Source: Supportive care in cancer : official journal of the Multinational Association of Supportive Care in Cancer [Support Care Cancer] 2020 Feb; Vol. 28 (2), pp. 925-932. Date of Electronic Publication: 2019 Jun 07.

Publication Type: Journal Article

Journal Info: Publisher: Springer International Country of Publication: Germany NLM ID: 9302957 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1433-7339 (Electronic) Linking ISSN: 09414355 NLM ISO Abbreviation: Support Care Cancer Subsets: MEDLINE

Authors: Denduluri N; Virginia Cancer Specialists, US Oncology Network, Arlington, VA. Electronic address: neelima.denduluri@usoncology.com., Lyman GH; Fred Hutchinson Cancer Research Center and the University of Washington, Seattle, WA., Wang Y; McKesson Specialty Health, The Woodlands, TX., Morrow PK; Amgen Inc, Thousand Oaks, CA., Barron R; Amgen Inc, Thousand Oaks, CA., Patt D; McKesson Specialty Health, The Woodlands, TX., Bhowmik D; Amgen Inc, Thousand Oaks, CA., Li X; Amgen Inc, Thousand Oaks, CA., Bhor M; McKesson Specialty Health, The Woodlands, TX., Fox P; McKesson Specialty Health, The Woodlands, TX., Dhanda R; McKesson Specialty Health, The Woodlands, TX., Saravanan S; McKesson Specialty Health, The Woodlands, TX., Jiao X; McKesson Specialty Health, The Woodlands, TX., Garcia J; Amgen Inc, Thousand Oaks, CA., Crawford J; Duke University Medical Center, Durham, NC.

Source: Clinical breast cancer [Clin Breast Cancer] 2018 Oct; Vol. 18 (5), pp. 380-386. Date of Electronic Publication: 2018 Feb 16.

Publication Type: Journal Article; Research Support, Non-U.S. Gov't

Journal Info: Publisher: Elsevier Country of Publication: United States NLM ID: 100898731 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1938-0666 (Electronic) Linking ISSN: 15268209 NLM ISO Abbreviation: Clin Breast Cancer Subsets: MEDLINE

Authors: Wei AH; Alfred Hospital and Monash University, Melbourne, VIC, Australia. Electronic address: Andrew.wei@monash.edu., Roberts AW; University of Melbourne, Royal Melbourne Hospital, Walter and Eliza Hall Institute of Medical Research, Melbourne, VIC, Australia., Spencer A; Alfred Hospital, Monash University, Australian Centre for Blood Diseases, Melbourne, VIC, Australia., Rosenberg AS; University of California Davis School of Medicine, Sacramento, CA, USA., Siegel D; John Theurer Cancer Center at Hackensack University Medical Center, Hackensack, NJ, USA., Walter RB; Clinical Research Division, Fred Hutchinson Cancer Research Center, Seattle, WA, USA., Caenepeel S; Amgen Inc., Thousand Oaks, CA, USA., Hughes P; Amgen Inc., Thousand Oaks, CA, USA., McIver Z; Amgen Inc., Thousand Oaks, CA, USA., Mezzi K; Amgen Inc., Thousand Oaks, CA, USA., Morrow PK; Amgen Inc., Thousand Oaks, CA, USA., Stein A; Gehr Family Center for Leukemia, City of Hope Medical Center, Duarte, CA, USA.

Source: Blood reviews [Blood Rev] 2020 Nov; Vol. 44, pp. 100672. Date of Electronic Publication: 2020 Feb 21.

Publication Type: Journal Article; Research Support, N.I.H., Extramural; Research Support, Non-U.S. Gov't; Review

Journal Info: Publisher: Elsevier Country of Publication: England NLM ID: 8708558 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1532-1681 (Electronic) Linking ISSN: 0268960X NLM ISO Abbreviation: Blood Rev Subsets: MEDLINE

MeSH Terms: Antineoplastic Agents/*pharmacology , Hematologic Neoplasms/*genetics , Leukemia, Myeloid, Acute/*genetics , Multiple Myeloma/*genetics , Myeloid Cell Leukemia Sequence 1 Protein/*antagonists & inhibitors , Myeloid Cell Leukemia Sequence 1 Protein/*genetics, Animals ; Antineoplastic Agents/therapeutic use ; Gene Expression Regulation, Neoplastic/drug effects ; Hematologic Neoplasms/drug therapy ; Hematologic Neoplasms/metabolism ; Humans ; Leukemia, Myeloid, Acute/drug therapy ; Leukemia, Myeloid, Acute/metabolism ; Molecular Targeted Therapy ; Multiple Myeloma/drug therapy ; Multiple Myeloma/metabolism ; Myeloid Cell Leukemia Sequence 1 Protein/analysis ; Myeloid Cell Leukemia Sequence 1 Protein/metabolism ; Signal Transduction/drug effects ; Up-Regulation/drug effects

Authors: Dale DC; Department of Medicine, University of Washington, 1959 NE Pacific St, Seattle, WA, 98195, USA. dcdale@uw.edu., Crawford J; Duke Cancer Institute, Duke University Medical Center, 30 Duke Medicine Circle, Duke South 25177 Morris Bldg, Durham, NC, 27710, USA., Klippel Z; Clinical Development, Amgen Inc., 1 Amgen Center Drive, Thousand Oaks, CA, 91320, USA., Reiner M; Global Biostatistical Sciences, Amgen Inc., 1 Amgen Center Drive, Thousand Oaks, CA, 91320, USA., Osslund T; Pre-Pivotal Drug Product Technologies, Amgen Inc., 1 Amgen Center Drive, Thousand Oaks, CA, 91320, USA., Fan E; Global Scientific Affairs, Amgen Inc., 1 Amgen Center Drive, Thousand Oaks, CA, 91320, USA., Morrow PK; Clinical Development, Amgen Inc., 1 Amgen Center Drive, Thousand Oaks, CA, 91320, USA., Allcott K; Oxford PharmaGenesis Ltd, Tubney Warren Barn, Tubney, Oxford, OX13 5QJ, UK., Lyman GH; Department of Medicine, University of Washington, 1959 NE Pacific St, Seattle, WA, 98195, USA.; Public Health Sciences Division and Clinical Research Division, Fred Hutchinson Cancer Research Center, Seattle, WA, 98109, USA.

Source: Supportive care in cancer : official journal of the Multinational Association of Supportive Care in Cancer [Support Care Cancer] 2018 Jan; Vol. 26 (1), pp. 7-20. Date of Electronic Publication: 2017 Sep 22.

Publication Type: Journal Article; Meta-Analysis; Review; Systematic Review

Journal Info: Publisher: Springer International Country of Publication: Germany NLM ID: 9302957 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1433-7339 (Electronic) Linking ISSN: 09414355 NLM ISO Abbreviation: Support Care Cancer Subsets: MEDLINE

Authors: Baig H; 1 IQVIA, Plymouth Meeting, USA., Somlo B; 1 IQVIA, Plymouth Meeting, USA., Eisen M; 2 Amgen Inc., Thousand Oaks, USA., Stryker S; 3 Amgen Inc., South San Francisco, USA., Bensink M; 2 Amgen Inc., Thousand Oaks, USA., Morrow PK; 2 Amgen Inc., Thousand Oaks, USA.

Source: Journal of oncology pharmacy practice : official publication of the International Society of Oncology Pharmacy Practitioners [J Oncol Pharm Pract] 2019 Oct; Vol. 25 (7), pp. 1576-1585. Date of Electronic Publication: 2018 Sep 10.

Publication Type: Journal Article

Journal Info: Publisher: SAGE Publications Country of Publication: England NLM ID: 9511372 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1477-092X (Electronic) Linking ISSN: 10781552 NLM ISO Abbreviation: J Oncol Pharm Pract Subsets: MEDLINE

MeSH Terms: Antineoplastic Agents/*adverse effects , Febrile Neutropenia/*prevention & control , Filgrastim/*therapeutic use , Neoplasms/*drug therapy , Polyethylene Glycols/*therapeutic use, Adolescent ; Adult ; Aged ; Female ; Humans ; Male ; Middle Aged ; Risk Factors ; Young Adult

Authors: Yang BB; Amgen Inc., One Amgen Center Dr, Thousand Oaks, CA, 91320, USA, byang@amgen.com., Morrow PK, Wu X, Moxness M, Padhi D

Source: Cancer chemotherapy and pharmacology [Cancer Chemother Pharmacol] 2015 Jun; Vol. 75 (6), pp. 1199-206. Date of Electronic Publication: 2015 Apr 17.

Publication Type: Clinical Trial, Phase I; Journal Article; Randomized Controlled Trial

Journal Info: Publisher: Springer Verlag Country of Publication: Germany NLM ID: 7806519 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1432-0843 (Electronic) Linking ISSN: 03445704 NLM ISO Abbreviation: Cancer Chemother Pharmacol Subsets: MEDLINE

Authors: Morrow PK; Department of Breast Medical Oncology, The University of Texas MD Anderson Cancer Center, Houston, TX. Electronic address: pmorrow@amgen.com., Broxson AC; Department of Breast Medical Oncology, The University of Texas MD Anderson Cancer Center, Houston, TX., Munsell MF; Department of Biostatistics, The University of Texas MD Anderson Cancer Center, Houston, TX., Basen-Enquist K; Department of Behavioral Sciences, The University of Texas MD Anderson Cancer Center, Houston, TX., Rosenblum CK; Department of Behavioral Sciences, The University of Texas MD Anderson Cancer Center, Houston, TX., Schover LR; Department of Behavioral Sciences, The University of Texas MD Anderson Cancer Center, Houston, TX., Nguyen LH; Department of Health Disparities Research, The University of Texas MD Anderson Cancer Center, Houston, TX., Hsu L; Department of Breast Medical Oncology, The University of Texas MD Anderson Cancer Center, Houston, TX., Castillo L; Department of Breast Medical Oncology, The University of Texas MD Anderson Cancer Center, Houston, TX., Hahn KM; Department of Breast Medical Oncology, The University of Texas MD Anderson Cancer Center, Houston, TX., Litton JK; Department of Breast Medical Oncology, The University of Texas MD Anderson Cancer Center, Houston, TX., Kwiatkowski DN; Department of Breast Medical Oncology, The University of Texas MD Anderson Cancer Center, Houston, TX., Hortobagyi GN; Department of Breast Medical Oncology, The University of Texas MD Anderson Cancer Center, Houston, TX.

Source: Clinical breast cancer [Clin Breast Cancer] 2014 Apr; Vol. 14 (2), pp. e21-31. Date of Electronic Publication: 2013 Oct 25.

Publication Type: Journal Article; Research Support, N.I.H., Extramural; Research Support, Non-U.S. Gov't; Review

Journal Info: Publisher: Elsevier Country of Publication: United States NLM ID: 100898731 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1938-0666 (Electronic) Linking ISSN: 15268209 NLM ISO Abbreviation: Clin Breast Cancer Subsets: MEDLINE

Authors: Guinigundo AS; Oncology Hematology Care Inc., Cincinnati, Ohio., Maxwell CL; TESARO Inc., Waltham, Massachusetts., Vanni L; Providence Hospital, Southfield, Michigan., Morrow PK; Amgen Inc., Thousand Oaks, California., Reiner M; Amgen Inc., Thousand Oaks, California., Shih A; Amgen Inc., Thousand Oaks, California., Klippel Z; Amgen Inc., Thousand Oaks, California., Blanchard E; Southcoast Health, New Bedford, Massachusetts. Electronic address: blancharde@southcoast.org.

Source: Pain management nursing : official journal of the American Society of Pain Management Nurses [Pain Manag Nurs] 2018 Dec; Vol. 19 (6), pp. 693-706. Date of Electronic Publication: 2018 Jun 21.

Publication Type: Journal Article; Multicenter Study; Randomized Controlled Trial; Research Support, Non-U.S. Gov't

Journal Info: Publisher: WB Saunders Co Country of Publication: United States NLM ID: 100890606 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1532-8635 (Electronic) Linking ISSN: 15249042 NLM ISO Abbreviation: Pain Manag Nurs Subsets: MEDLINE

MeSH Terms: Patient Education as Topic*, Bone Neoplasms/*drug therapy , Breast Neoplasms/*drug therapy , Pain, Intractable/*prevention & control, Aged ; Anti-Inflammatory Agents, Non-Steroidal/administration & dosage ; Anti-Inflammatory Agents, Non-Steroidal/therapeutic use ; Antineoplastic Combined Chemotherapy Protocols/administration & dosage ; Antineoplastic Combined Chemotherapy Protocols/therapeutic use ; Bone Neoplasms/secondary ; Breast Neoplasms/pathology ; Female ; Filgrastim/administration & dosage ; Filgrastim/therapeutic use ; Humans ; Middle Aged ; Neoplasm Metastasis ; Pain Management/nursing ; Pain Measurement ; Pain, Intractable/nursing ; Polyethylene Glycols/administration & dosage ; Polyethylene Glycols/therapeutic use ; Single-Blind Method ; Treatment Outcome ; United States ; Video Recording

Authors: Kirshner JJ; Hematology-Oncology Associates of Central New York, 5008 Brittonfield Parkway, East Syracuse, NY, 13057, USA. jkirshner@hoacny.com., McDonald MC 3rd; Willis Knighton Cancer Center, Shreveport, LA, USA., Kruter F; William E Kahlert Regional Cancer Center, Westminster, MD, USA., Guinigundo AS; Oncology Hematology Care Inc., Cincinnati, OH, USA., Vanni L; Ascension Providence, Southfield, MI, USA., Maxwell CL; TESARO Inc., Waltham, MA, USA., Reiner M; Amgen Inc., Thousand Oaks, CA, USA., Upchurch TE; Amgen Inc., Thousand Oaks, CA, USA., Garcia J; Amgen Inc., Thousand Oaks, CA, USA.; Juno Therapeutics Inc., Seattle, WA, USA., Morrow PK; Amgen Inc., Thousand Oaks, CA, USA.

Source: Supportive care in cancer : official journal of the Multinational Association of Supportive Care in Cancer [Support Care Cancer] 2018 Apr; Vol. 26 (4), pp. 1323-1334. Date of Electronic Publication: 2017 Nov 16.

Publication Type: Clinical Trial, Phase II; Journal Article; Multicenter Study; Randomized Controlled Trial

Journal Info: Publisher: Springer International Country of Publication: Germany NLM ID: 9302957 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1433-7339 (Electronic) Linking ISSN: 09414355 NLM ISO Abbreviation: Support Care Cancer Subsets: MEDLINE

MeSH Terms: Bone Diseases/*prevention & control , Breast Neoplasms/*drug therapy , Loratadine/*therapeutic use , Naproxen/*therapeutic use , Pain/*prevention & control, Adult ; Aged ; Aged, 80 and over ; Antineoplastic Combined Chemotherapy Protocols/adverse effects ; Bone Diseases/chemically induced ; Breast Neoplasms/pathology ; Female ; Filgrastim/adverse effects ; Granulocyte Colony-Stimulating Factor/therapeutic use ; Humans ; Middle Aged ; Pain/etiology ; Pain Management/methods ; Polyethylene Glycols/adverse effects ; Young Adult

Authors: Bayraktar S; Division of Cancer Medicine, The University of Texas MD Anderson Cancer Center, Houston, TX, USA. soley.bayraktar@gmail.com, Gutierrez-Barrera AM, Lin H, Elsayegh N, Tasbas T, Litton JK, Ibrahim NK, Morrow PK, Green M, Valero V, Booser DJ, Hortobagyi GN, Arun BK

Source: Clinical & experimental metastasis [Clin Exp Metastasis] 2013 Jun; Vol. 30 (5), pp. 631-42. Date of Electronic Publication: 2013 Feb 01.

Publication Type: Journal Article; Research Support, N.I.H., Extramural; Research Support, Non-U.S. Gov't

Journal Info: Publisher: Kluwer Academic Publishers Country of Publication: Netherlands NLM ID: 8409970 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1573-7276 (Electronic) Linking ISSN: 02620898 NLM ISO Abbreviation: Clin Exp Metastasis Subsets: MEDLINE